Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Hydrocodone bitartrate; phenylpropanolamine hydrochloride

Hydrocodone bitartrate; phenylpropanolamine hydrochloride: 0 brands, 1 generic; first approved Sep 29, 2000; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
0
Generics (ANDA)
1
Listed patents
0
Presentations
1

Generic (ANDA) products (1)

Abbreviated applications
  • ANDA 0751032000
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    5MG/5ML;25MG/5MLSYRUPORALDiscontinued

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
26 yr 2 mo ago
Most recent approval
26 yr 2 mo ago

All 1 application were approved in 2000.

Brand (NDA) 00%
Generic (ANDA) 1100%

Hydrocodone bitartrate; phenylpropanolamine hydrochloride: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.